AdaptHealth Corp. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm

This post was originally published on this site

Investors with losses are encouraged to contact the firm before September 27, 2021; click here to submit trade information

LOS ANGELES, Sept. 14, 2021 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of AdaptHealth (NASDAQ: AHCO) investors that acquired shares between November 11, 2019 to July 16, 2021. Investors have until September 27, 2021 to seek an active role in this litigation.

Investors are encouraged to contact attorney Lesley F. Portnoy, to determine eligibility to participate in this action, by phone 310-692-8883 or email, or click here to join the case.

It is alleged in this lawsuit that, throughout the Class Period, defendants made misleading and false statements and failed to disclose that: (i) AdaptHealth had misrepresented its organic growth trajectory by inflating past organic growth numbers retroactively without disclosing the changes, in violation of U.S. Securities and Exchange Commission (“SEC”) regulations; (ii) AdaptHealth had materially overstated its financial prospects, accordingly; and (iii) AdaptHealth’s public statements were materially misleading and false at all relevant times, as a result.

A report was published by Jehoshaphat Research on July 19, 2012 alleging that AdaptHealth is a “roll-up” company, or a company that is built primarily through the acquisition of smaller companies with common services or products, obscuring its organic growth by “[r]etroactively changing past organic growth numbers to be higher, with no disclosure about the change.” The report stated specifically that “[w]hile management claims (and consensus estimates reflect) an organic growth trajectory of 8-10%, AHCO is in fact experiencing double-digit organic decline. It is also, in our opinion, taking steps to obscure that decline which are expressly forbidden by the SEC.” It is suggested in this report that AdaptHealth’s manipulation of its organic growth trajectory was “a blatant violation of non-GAAP disclosure rules, for which companies get into huge trouble.” AdaptHealth’s stock price fell nearly 6% on this news, damaging investors.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 27, 2021.

Please visit our website to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar

Attorney Advertising